Brandon McMahon
Overview
Explore the profile of Brandon McMahon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gotlib J, Gerds A, Abdelmessieh P, Ali H, Castells M, Dunbar A, et al.
J Natl Compr Canc Netw
. 2024 Jun;
22(2 D).
PMID: 38862005
Mastocytosis is a heterogeneous group of disorders comprising cutaneous mastocytosis, systemic mastocytosis, and mast cell sarcoma. It is associated with a variety of symptoms related to the release of mast...
2.
McCormick C, McMahon B, Galatowitsch J, Castillo A
NEJM Evid
. 2024 Feb;
2(5):EVIDmr2300047.
PMID: 38320053
A 35-Year-Old Man with FeverA 35-year-old man presented for evaluation of fever for 2 weeks with left-sided abdominal pain. How do you approach the evaluation, and what is the diagnosis?
3.
Schreiber A, Santos J, McMahon B, Buckner T, Olson C, Alberti M, et al.
N Engl J Med
. 2023 Aug;
389(7):668-670.
PMID: 37585636
No abstract available.
4.
Halsema K, McMahon B
J Adv Pract Oncol
. 2023 May;
14(3):213-217.
PMID: 37197728
The risk of developing venous thromboembolism (VTE) is four to seven times higher in patients with cancer than in those without. At JADPRO Live 2022, presenters discussed risk factors and...
5.
Moyo T, Kishtagari A, Villaume M, McMahon B, Mohan S, Stopczynski T, et al.
Clin Cancer Res
. 2023 Apr;
29(13):2375-2384.
PMID: 37036505
Purpose: Treatment options are limited beyond JAK inhibitors for patients with primary myelofibrosis (MF) or secondary MF. Preclinical studies have revealed that PI3Kδ inhibition cooperates with ruxolitinib, a JAK1/2 inhibitor,...
6.
Gerds A, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A, et al.
J Natl Compr Canc Netw
. 2022 Sep;
20(9):1033-1062.
PMID: 36075392
The classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a heterogeneous group of clonal blood disorders characterized by an overproduction of blood...
7.
Streiff M, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, et al.
J Natl Compr Canc Netw
. 2021 Oct;
19(10):1181-1201.
PMID: 34666313
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of patients with cancer who have developed or who are...
8.
Gerds A, Gotlib J, Bose P, Deininger M, Dunbar A, Elshoury A, et al.
J Natl Compr Canc Netw
. 2020 Sep;
18(9):1248-1269.
PMID: 32886902
Eosinophilic disorders and related syndromes represent a heterogeneous group of neoplastic and nonneoplastic conditions, characterized by more eosinophils in the peripheral blood, and may involve eosinophil-induced organ damage. In the...
9.
Kolb J, Conzen K, Wachs M, Crossno Jr J, McMahon B, Abidi M, et al.
Hepatology
. 2020 Jan;
72(1):356-358.
PMID: 31943309
No abstract available.
10.
TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
Davizon-Castillo P, McMahon B, Aguila S, Bark D, Ashworth K, Allawzi A, et al.
Blood
. 2019 Jul;
134(9):727-740.
PMID: 31311815
Aging and chronic inflammation are independent risk factors for the development of atherothrombosis and cardiovascular disease. We hypothesized that aging-associated inflammation promotes the development of platelet hyperreactivity and increases thrombotic...